Evidence map›Paper›PMID 20593238›Full record

ArticlePharmacy world & science : PWS2010

Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany.

Thomas Fiss, Christoph Alexander Ritter, Dietrich Alte, Neeltje van den Berg, Wolfgang Hoffmann

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Pharmacy world & science : PWS, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01401582 (Dementia), which is not on this map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01401582 nacompletednot on this mapstarted 2012, after this paper: background citation

Dementia: Life- and Personcentered Help in Germany

TypeinterventionalSponsorGerman Center for Neurodegenerative Diseases (DZNE)Ran2012 to 2024Enrolled634ConditionsDementiaArmsImplementation of Dementia Care Manager
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. The pharmacist and the EHR.Journal of the American Medical Informatics Association : JAMIA · 2017
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thomas FissInstitute for Community Medicine, Section Epidemiology of Health Care and Community Health, Ernst Moritz Arndt University of Greifswald, Ellernholzstr. 1-2, 17487, Greifswald, Germany. Thomas.Fiss@uni-greifswald.de
Christoph Alexander Ritter
Dietrich Alte
Neeltje van den Berg
Wolfgang Hoffmann

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe disparity between an increasing complexity of patients' treatment and the declining number of general practitioners (GP) require action. The AGnES-concept (general practitioner-relieving, community-based, e-health assisted, systemic intervention) is based on the delegation of original physician-activities to qualified AGnES-practice assistants. Purposes of AGnES part 1 were to determine the feasibility of community-based home medication reviews (HMR) and the establishment of a health professional network to identify drug related problems (DRP) in the domicile of elderly patients. Two consecutive studies (AGNES 2 + 3) were conducted to implement HMR.

settingGeneral practices on the isle of Rugia in Mecklenburg-Western Pomerania, a German rural area. Patients who receive regular home visits by their GP were addressed.

methodStudy-instruments for the feasibility study (AGnES 1) were designed by an expert panel and modified for the implementation (AGnES 2 + 3) studies. HMR were conducted by additionally qualified AGnES-practice assistants regarding DRP like drug-drug interaction (DDI), adverse drug reactions (ADR), and compliance. DRP-selection was inspired by the coding system Pi-Doc. Pharmacists checked DRP and intervened, if necessary. 18 (AGnES 1) and 60 (AGnES 2 + 3) geriatric patients received a minimum of two home visits by an AGnES-practice assistant.

main outcome measureFeasibility was assessed by patients' satisfaction with care provided by the AGnES-practice assistant. For implementation reported DRP and the conducted interventions were evaluated.

resultsDuring AGnES 1 a documentation sheet was developed and tested. 56 potential DDI were identified. 37 of 112 drugs which caused potential interactions were attributed to OTC medication and food components. 84% of respondents judged the systematic evaluation of their pharmacotherapy as helpful. During AGnES 2 + 3 local pharmacists identified DDIs in 45% of patients. Seven patients (11.6%) reported at least one ADR attributable to their current medication. Those patients who received a second HMR (n = 29) during AGnES 2 + 3 rated the HMR as reasonable 65.5% (n = 19), and partly reasonable 24.1% (n = 7).

conclusionsBy comprehensive HMR conducted by AGnES-practice assistants in delegation of the patients' GPs in cooperation with local pharmacists we could identify a considerable prevalence of DRP under real-life conditions. Further studies should recruit more participants including a control group with usual care.

Indexed as

Drug-Related Side Effects and Adverse ReactionsDrug Utilization ReviewPatient Care TeamAgedAged, 80 and overDelegation, ProfessionalDelivery of Health CareDrug InteractionsFeasibility StudiesFemaleGermanyHomebound PersonsHome Care ServicesHumansInterviews as TopicMale

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.